1. What Is the Point of Care Chip Market?
The Point of Care Chip Market covers semiconductor and microfluidic chip devices enabling rapid diagnostic testing at the site of patient care without centralised laboratory infrastructure. Point of care chip encompasses lateral flow assay chips, microfluidic cartridge chips, semiconductor biosensor chips, and integrated sample-to-answer chip platforms for infectious disease, chronic disease monitoring, and metabolite measurement. Market dynamics reflect post-pandemic infrastructure investment in decentralised testing, chronic disease management driving continuous biomarker monitoring, and regulatory framework expansion for point-of-care diagnostic clearance.
2. Point of Care Chip Market Size & Forecast
3. Emerging Technologies
- AI-integrated POC chip platforms performing on-chip pattern recognition for molecular test result interpretation without external reader are advancing as autonomous diagnostic tools. Growing adoption in resource-limited settings is driven by reader hardware cost elimination requirements.
- Multiplexed POC chips testing 10 or more analytes simultaneously from a single finger-prick blood sample are advancing as comprehensive diagnostic panels. Growing adoption at primary care is driven by multi-disease screening efficiency requirements.
- Implantable continuous monitoring chips measuring glucose, ketone, and lactate from subcutaneous tissue for chronic disease management are advancing. Growing adoption is driven by continuous biomarker monitoring beyond intermittent fingerstick testing.
- Home-use POC chips cleared for consumer self-testing of hepatitis, HIV, and cardiac markers are advancing as direct-to-consumer diagnostic tools. Growing adoption is driven by health awareness and early detection preferences.
Such innovations are driving change across adjacent industries too. Discover more in our Lab On Chip Market.
4. Key Market Opportunity
Revenue is concentrated in the Point of Care Chip Market at the continuous glucose monitor sensor chip sub-market, where diabetic population growth and CGM clinical benefit evidence create large recurring sensor consumable revenue. Molecular POC chip expansion for antimicrobial resistance and respiratory panel testing creates a high-value acute care revenue opportunity. Home-use POC chip clearance expansion creates a large direct-to-consumer diagnostic revenue channel. Asia Pacific POC chip adoption creates geographic expansion as large diabetic populations in China and India drive CGM and chronic disease monitoring chip demand.
5. Top Companies in the Point of Care Chip Market
The following organisations hold leading positions in the Point of Care Chip Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Abbott (i-STAT, FreeStyle Libre)
- Cepheid (Danaher)
- Dexcom
- Roche (cobas pulse)
- Biosite (Alere)
- Siemens Healthineers
- Becton Dickinson
- Chembio
- Qorvo Biotechnologies
- Meso Scale Diagnostics
6. Market Segmentation
The Point of Care Chip Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Technology | Lateral Flow ChipMicrofluidic CartridgeSemiconductor BiosensorElectrochemicalOptical |
| By Application | Infectious DiseaseCardiac MarkersGlucoseCoagulationMolecular POC |
| By Setting | Hospital EmergencyPrimary CarePharmacyHome Use |
| By Geography | North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Point of Care Chip Market trajectory over the forecast period:
Abbott i-STAT Alinity POC Chip Platform Achieves 1 Million Daily Tests Across Hospital Networks.Abbott i-STAT Alinity POC chip reaching 1 million daily critical care tests at US hospital networks in 2024 demonstrates chip-based POC testing scale in acute care. The i-STAT Alinity chip-based panels measuring cardiac, metabolic, and coagulation markers within 5 minutes demonstrate rapid acute care clinical utility.
Cepheid GeneXpert Molecular POC Chip Achieves 23,000 System Deployments for Infectious Disease Diagnosis.Cepheid GeneXpert molecular POC platform achieving 23,000 system deployments including 6,500 in low-income countries in 2024 demonstrates global POC molecular diagnostics scale. GeneXpert cartridge chip integrating DNA extraction, amplification, and detection in a single consumable achieving 99 percent sensitivity for tuberculosis demonstrates infectious disease performance.
Continuous Glucose Monitor Chips Drive Large-Scale Commercial Adoption of Biosensor Wearable Diagnostics.Abbott FreeStyle Libre CGM chip achieving 6 million active sensor users in 2024 and Dexcom G7 achieving 2.4 million users represents the largest single chip-based diagnostic device adoption. CGM sensor chip enabling 15-day continuous subcutaneous glucose measurement without fingerstick calibration demonstrates biosensor chip consumer diagnostic commercial scale.
For related market intelligence, see the Battery Soc Market.
8. Segmental Analysis
By technology, the Semiconductor Biosensor and Continuous Monitor segment dominated the Point of Care Chip Market in 2025. Representing the largest revenue category as CGM sensor chips achieve mass-market consumer adoption. The Molecular POC Chip segment is the fastest-growing category, advancing as multiplex respiratory and AMR panels expand point-of-care molecular testing beyond COVID-19.
By setting, the Hospital Emergency segment dominated the Point of Care Chip Market in 2025. Representing the largest setting revenue share. The Home Use segment is the fastest-growing setting category, advancing as cloud-native deployment lowers adoption cost and expands mid-market buyer access. Both setting dimensions indicate active transition between established Hospital Emergency demand and emerging Home Use adoption.
By application, the Infectious Disease segment dominated the Point of Care Chip Market in 2025, as respiratory panel, influenza, and sexually transmitted infection chip assays generate the highest volume diagnostic chip deployment. Molecular POC is the fastest-growing application category, driven by FDA-authorised point-of-care molecular diagnostic systems enabling rapid PCR-equivalent pathogen identification outside laboratory settings.
9. Regional Analysis
Regional demand patterns across the Point of Care Chip Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Point of Care Chip Market in 2025, holding 46.7% of the global market. Clinical laboratory operators, emergency department physicians, and point-of-care testing networks are deploying point-of-care chip-based diagnostic platforms to enable rapid, decentralised testing for critical care analytes in clinical settings. FDA waiver pathways for point-of-care chip diagnostics and growing CMS reimbursement for decentralised testing are encouraging healthcare providers to invest in chip-based POC testing infrastructure. High healthcare spending, expanding ambulatory care networks, and growing demand for rapid diagnostic results are generating strong regional demand for point-of-care chip diagnostic platforms.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 21.97% during the forecast period. Government public health infrastructure investment and expanding primary care networks across China, India, and Southeast Asia are creating institutional demand for point-of-care chip diagnostic platforms that deliver laboratory-quality results in decentralised settings. Rising burden of infectious disease, growing demand for community-based screening programmes, and expanding rural healthcare access initiatives are driving adoption of portable chip-based diagnostic tools. Increasing investment in pandemic preparedness infrastructure and growing demand for rapid molecular diagnostics are generating new deployment opportunities.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Point of Care Chip Market was valued at USD 2.40 Bn in 2025 and is projected to reach USD 9.35 Bn by 2034, growing at a CAGR of 16.3% over the 2026–2034 forecast period.
The Point of Care Chip Market is projected to grow at a CAGR of 16.3% from 2026 to 2034.
North America accounted for the largest share of the Point of Care Chip Market in 2025, holding 46.7% of the global market.
The leading companies in the Point of Care Chip Market include Abbott (i-STAT, FreeStyle Libre), Cepheid (Danaher), Dexcom, Roche (cobas pulse), Biosite (Alere), Siemens Healthineers, Becton Dickinson, Chembio, Qorvo Biotechnologies, Meso Scale Diagnostics.
Abbott i-stat alinity poc chip platform achieves 1 million daily tests across hospital networks.
By technology, the Semiconductor Biosensor and Continuous Monitor segment dominated the Point of Care Chip Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.